Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014088170> ?p ?o ?g. }
- W2014088170 endingPage "233" @default.
- W2014088170 startingPage "229" @default.
- W2014088170 abstract "Trastuzumab in conjunction with adjuvant chemotherapy markedly improves outcome. In the Netherlands, a national guideline was released in September 2005 stating that trastuzumab should be given in conjunction with adjuvant chemotherapy in women with HER2-positive breast cancer. Aim of this study was to identify the number of women with HER2-positive breast cancer and to evaluate the level of implementation of adjuvant trastuzumab in clinical practice nationwide. Women diagnosed with primary breast cancer between September 2005 and January 2007 were selected from the Netherlands Cancer Registry (NCR). HER2 status, adjuvant treatment and reasons to withhold trastuzumab were registered. 14,934 Breast cancer patients were diagnosed in this period of whom 1,928 (13%) had a HER2-positive tumour. Of all HER2-positive women receiving adjuvant chemotherapy, 66 (6%) did not receive trastuzumab. This percentage decreased from 10% at the time of introduction of the guideline to 4% in the study period September 2005–December 2006. Most common reasons to withhold trastuzumab were cardiovascular disease (29%) and patient refusal (21%). Of all HER2-positive patients who received adjuvant chemotherapy, 94% received trastuzumab. The implementation of trastuzumab in clinical practice was realized within 8 months after introduction of the new guideline." @default.
- W2014088170 created "2016-06-24" @default.
- W2014088170 creator A5000350948 @default.
- W2014088170 creator A5012843588 @default.
- W2014088170 creator A5020517461 @default.
- W2014088170 creator A5045983851 @default.
- W2014088170 creator A5049859418 @default.
- W2014088170 creator A5054754505 @default.
- W2014088170 creator A5075329771 @default.
- W2014088170 creator A5078581728 @default.
- W2014088170 date "2011-03-24" @default.
- W2014088170 modified "2023-10-18" @default.
- W2014088170 title "Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands" @default.
- W2014088170 cites W1999368908 @default.
- W2014088170 cites W2043905676 @default.
- W2014088170 cites W2071130163 @default.
- W2014088170 cites W2095156669 @default.
- W2014088170 cites W2099630695 @default.
- W2014088170 cites W2107413762 @default.
- W2014088170 cites W2123433191 @default.
- W2014088170 cites W2128958667 @default.
- W2014088170 cites W2141393790 @default.
- W2014088170 cites W2146384083 @default.
- W2014088170 cites W2149908785 @default.
- W2014088170 doi "https://doi.org/10.1007/s10549-011-1451-0" @default.
- W2014088170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21431871" @default.
- W2014088170 hasPublicationYear "2011" @default.
- W2014088170 type Work @default.
- W2014088170 sameAs 2014088170 @default.
- W2014088170 citedByCount "36" @default.
- W2014088170 countsByYear W20140881702012 @default.
- W2014088170 countsByYear W20140881702013 @default.
- W2014088170 countsByYear W20140881702014 @default.
- W2014088170 countsByYear W20140881702015 @default.
- W2014088170 countsByYear W20140881702016 @default.
- W2014088170 countsByYear W20140881702017 @default.
- W2014088170 countsByYear W20140881702018 @default.
- W2014088170 countsByYear W20140881702019 @default.
- W2014088170 countsByYear W20140881702020 @default.
- W2014088170 countsByYear W20140881702021 @default.
- W2014088170 countsByYear W20140881702022 @default.
- W2014088170 crossrefType "journal-article" @default.
- W2014088170 hasAuthorship W2014088170A5000350948 @default.
- W2014088170 hasAuthorship W2014088170A5012843588 @default.
- W2014088170 hasAuthorship W2014088170A5020517461 @default.
- W2014088170 hasAuthorship W2014088170A5045983851 @default.
- W2014088170 hasAuthorship W2014088170A5049859418 @default.
- W2014088170 hasAuthorship W2014088170A5054754505 @default.
- W2014088170 hasAuthorship W2014088170A5075329771 @default.
- W2014088170 hasAuthorship W2014088170A5078581728 @default.
- W2014088170 hasBestOaLocation W20140881702 @default.
- W2014088170 hasConcept C121608353 @default.
- W2014088170 hasConcept C126322002 @default.
- W2014088170 hasConcept C142724271 @default.
- W2014088170 hasConcept C143998085 @default.
- W2014088170 hasConcept C2776694085 @default.
- W2014088170 hasConcept C2777863537 @default.
- W2014088170 hasConcept C2777982462 @default.
- W2014088170 hasConcept C2779786085 @default.
- W2014088170 hasConcept C2780182762 @default.
- W2014088170 hasConcept C29456083 @default.
- W2014088170 hasConcept C530470458 @default.
- W2014088170 hasConcept C71924100 @default.
- W2014088170 hasConceptScore W2014088170C121608353 @default.
- W2014088170 hasConceptScore W2014088170C126322002 @default.
- W2014088170 hasConceptScore W2014088170C142724271 @default.
- W2014088170 hasConceptScore W2014088170C143998085 @default.
- W2014088170 hasConceptScore W2014088170C2776694085 @default.
- W2014088170 hasConceptScore W2014088170C2777863537 @default.
- W2014088170 hasConceptScore W2014088170C2777982462 @default.
- W2014088170 hasConceptScore W2014088170C2779786085 @default.
- W2014088170 hasConceptScore W2014088170C2780182762 @default.
- W2014088170 hasConceptScore W2014088170C29456083 @default.
- W2014088170 hasConceptScore W2014088170C530470458 @default.
- W2014088170 hasConceptScore W2014088170C71924100 @default.
- W2014088170 hasIssue "1" @default.
- W2014088170 hasLocation W20140881701 @default.
- W2014088170 hasLocation W20140881702 @default.
- W2014088170 hasLocation W20140881703 @default.
- W2014088170 hasLocation W20140881704 @default.
- W2014088170 hasLocation W20140881705 @default.
- W2014088170 hasLocation W20140881706 @default.
- W2014088170 hasLocation W20140881707 @default.
- W2014088170 hasOpenAccess W2014088170 @default.
- W2014088170 hasPrimaryLocation W20140881701 @default.
- W2014088170 hasRelatedWork W1822510418 @default.
- W2014088170 hasRelatedWork W2009578901 @default.
- W2014088170 hasRelatedWork W2016159668 @default.
- W2014088170 hasRelatedWork W2060393770 @default.
- W2014088170 hasRelatedWork W2977567559 @default.
- W2014088170 hasRelatedWork W3024061513 @default.
- W2014088170 hasRelatedWork W3114454420 @default.
- W2014088170 hasRelatedWork W3130246562 @default.
- W2014088170 hasRelatedWork W3143669913 @default.
- W2014088170 hasRelatedWork W4229958922 @default.
- W2014088170 hasVolume "129" @default.
- W2014088170 isParatext "false" @default.
- W2014088170 isRetracted "false" @default.